[Factors, affecting penicillin therapy].
D000667:Ampicillin / Q000032:analysis; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001991:Bronchitis / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D003023:Cloxacillin / Q000627:therapeutic use; D004304:Dosage Forms; D004336:Drug Antagonism; D004342:Drug Hypersensitivity; D004696:Endocarditis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007239:Infections / Q000188:drug therapy*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008581:Meningitis / Q000188:drug therapy; D008712:Methicillin / Q000627:therapeutic use; D010019:Osteomyelitis / Q000188:drug therapy; D010403:Penicillin Resistance; D010406:Penicillins / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D011339:Probenecid / Q000008:administration & dosage; D011485:Protein Binding; D011552:Pseudomonas Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D004304:Dosage Forms; D007166:Immunosuppressive Agents; D010406:Penicillins; D000667:Ampicillin; D002228:Carbenicillin; D003023:Cloxacillin; D011339:Probenecid; D008712:Methicillin
Faktory, vliiaiushchie na penitsillinovuiu terapiiu.